Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone is playing games. Every time I set a bid or hit the ask it gets moved and I can't get filled.
Wonder whose shares they're stealing....
Don't care when they release as long as results are positive.
Just bc it's 'there' doesn't mean it'll be used. And the # of shares is pretty typical
It's already starting as of about 330 pm
Perfectly normal amount
Agree, but find it kind of baffling that this hasn't caught more 'buzz' all things considered.
Even if it stays an IV drug only it's somewhat irrelevant. If it works, a bimonthly infusion is an easy price to pay to stay 'healthy'.
I think they're presenting the p2 data for their ms drug later this month.
Thanks! Expect we'll see more of that over the next few weeks.
Was there any news released?
All new theories are 'fringe science' until they're proven correct. That's how science works.
I'm on the road today so I can't help there but it was in one of their filings last year
They didn't 'arbitrarily' scrap the recent SPA, they got the 'ok' from the FDA to do that
Fib retrace. Nothing has changed since last week.
That was my initial thought...
You are 100% correct and your question is the right one.
The answer is yes and that's their potential $2-$5B annual market opportunity. That's why this will keep running (assuming good data).
The recent stuff is nice and I'll take it...but tackling B cells with minimal AE's is the big one.
Can't link it but it's in their latest slide deck from yesterday's presentation. It's def on their website.
Nice volume today
A lot more insider buying...what's it gonna take for this ticker to move?! At this rate the insiders are gonna take it private!
Talk about a shake! Anyone wanna bet we close green?
Yea...p2 in April. Last study showed a 99% depletion rate.
Agree, but very surprised it fell today
Your price range is very reasonable pre data release.
Agree with what you said, some days will be down but overall trend will be up.
Depends on how many shares you're trying to sell...but it's liquid enough to sell in 500-1000 share increments right now.
More volume would be helpful though
At current HOD it's trading at $0.70 pre split, very low MC. Still needs more volume though.
MS data out in April plus a slew of new 2H 2017
The answer is maybe...but that was never tested or looked at with those trials so we'll never know.
Very nice. Still can't believe how low this got
6+M outstanding 12.5M fully diluted.
Yea there have been lots of them. Ranging from $26-$33
Right...bc governments are GREAT at picking 'winners and losers'
Impossible to handicap that...if they do raise (and I assume they will), it'll likely be after the uplist and will likely be a private placement. JMHO
They already raised last year, but they may want to do that again before the data release...would be the prudent thing to do.
There was a hard sell off yesterday and it recovered nicely...some days will be up big and some days it'll sell off hard. Just the nature of this stock until data...but the general trend will be up until then.
As of last week they said 'any day now'... it's out of their control at the moment
They have ZERO need for funding right now. Assuming all warrants are exercised that would bring the float to 12.5M shares, and add $60M to their coffers.
Will they sell additional shares now that they've increased the authorized share count? Most likely, as most companies do...but that assumes no partnership which seems unlikely if data is good.
As always, it comes down to the science and data.
This was announced last month. They need the ability to raise funds if they don't partner. Not a big deal.
You aren't factoring in the 32 : 1 reverse split
I think they presented today, someone must have like it.